InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Fruchtman Steven M, Chief Executive Officer. Officer active across 1 companies, notably Onconova Therapeutics, Inc.. Aggregated, 2 reports have been logged. Total volume traded: €17k. The latest transaction was disclosed on 28 September 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€8,5572,381 shares@ €3.5939100.0% of flow
Common Stock
SEC:0001179110-21-008956·
Ideal exit: 25 Jun 2022 (T+270)
€8,5572,381 shares@ €3.593950.0% of flow
Common Stock
SEC:0001179110-21-008956:0·
Ideal exit: 25 Jun 2022 (T+270)
2 of 2 declarations
About Fruchtman Steven M
Steven M Fruchtman is the President and Chief Executive Officer of Onconova Therapeutics, Inc. He is responsible for the strategic direction of the company, overseeing operations and development initiatives. His expertise in the biopharmaceutical sector is essential for guiding the company's growth and innovation.
